CD95 (FAS/APO-1) Antigen is a New Prognostic Marker of Blast Cells of Acute Lymphoblastic Leukaemia Patients (original) (raw)

Abstract

We analyzed CD95(Fas/APO-l) antigen expression on bone marrow blasts in 38 children with acute lymphoblastic leukemia (ALL) receiving a treatment in the Department of Leukaemias at the Cancer Research Center in 1987–1989 years (n = 22) and in 1994–1997 years (n = 16). CD95 antigen expression was studied by monoclonal antibodies (MoAbs) IPO-4 in indirect immunofluorescence analysis. CD95 antigen was expressed on 35.8±7.5% bone marrow blasts, most frequently (63.6%) in the clinically favourable Pre-B ALL. Only in this group CD95 antigen expression was correlated with CD10 antigen expression that has a positive influence to the time of complete remission in ALL patients. Our data showed that CD95 expression on blast cells is a favourable prognostic sign, associated with increased relapse-free and total survival. On the contrary, the absence of CD95 antigen on blasts is an unfavourable sign for disease evolution.

Preview

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Baryshnikov A.Yu., Kadagidze Z.G., Tupitsin N.N., Machonova L.A.. Immunological phenotype of leukemic cell. Moscow, 1989, 240.
    Google Scholar
  2. Kotani T; Aratake Y; Kondo S; Tamura K; Ohtaki S. Expression of functional Fas antigen on adult T-cell leukemia. Leuk-Res., 1994, 18(4), 305–310
    Article PubMed CAS Google Scholar
  3. Lucking-Famira KM; Daniel PT; Moller P; Krammer PH; Debatin-KM APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia, 1994, 8(11), 1825–1833
    PubMed CAS Google Scholar
  4. Debatin K.-M., Goldman C.K., Waldman T.A., Krammer P.H. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia, Blood, 1993, 81, 2972–2977
    PubMed CAS Google Scholar
  5. Debatin K.-M., Goldman C.K., Bamford R. et al. Monoclonal antibody mediated apoptosis in adult T cell leukemia, Lancet, 1990, 335, 447
    Article Google Scholar
  6. Friesen C; Herr I; Krammer PH; Debatin KM. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat-Med., 1996, 2(5), 574–577
    Article PubMed CAS Google Scholar
  7. Brunner T., Mogil R.J., LaFase D., Yoo N.J., Mahboubl A. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature, 1995, 373, 441–444
    Article PubMed CAS Google Scholar
  8. Ju Shyr-Te, Panka D.J., Cui H., Ettinger R., Marshak-Rothstei. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature, 1995, 373, 444–448
    Article PubMed CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia
    A. Yu. Baryshnikov, E. R. Polosukhina, N. N. Tupitsin, N. V. Gavrikova, L. Yu. Andreeva, T. N. Zabotina, S. A. Mayakova, V. I. Kurmashov, A. B. Syrkin, Z. G. Kadagidze, D. Yu. Blochin & Yu. V. Shishkin

Authors

  1. A. Yu. Baryshnikov
    You can also search for this author inPubMed Google Scholar
  2. E. R. Polosukhina
    You can also search for this author inPubMed Google Scholar
  3. N. N. Tupitsin
    You can also search for this author inPubMed Google Scholar
  4. N. V. Gavrikova
    You can also search for this author inPubMed Google Scholar
  5. L. Yu. Andreeva
    You can also search for this author inPubMed Google Scholar
  6. T. N. Zabotina
    You can also search for this author inPubMed Google Scholar
  7. S. A. Mayakova
    You can also search for this author inPubMed Google Scholar
  8. V. I. Kurmashov
    You can also search for this author inPubMed Google Scholar
  9. A. B. Syrkin
    You can also search for this author inPubMed Google Scholar
  10. Z. G. Kadagidze
    You can also search for this author inPubMed Google Scholar
  11. D. Yu. Blochin
    You can also search for this author inPubMed Google Scholar
  12. Yu. V. Shishkin
    You can also search for this author inPubMed Google Scholar

Editor information

Editors and Affiliations

  1. University Hospital Vrije Universiteit, Amsterdam, The Netherlands
    G. J. L. Kaspers , R. Pieters & A. J. P. Veerman , &

Rights and permissions

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Baryshnikov, A.Y. et al. (1999). CD95 (FAS/APO-1) Antigen is a New Prognostic Marker of Blast Cells of Acute Lymphoblastic Leukaemia Patients. In: Kaspers, G.J.L., Pieters, R., Veerman, A.J.P. (eds) Drug Resistance in Leukemia and Lymphoma III. Advances in Experimental Medicine and Biology, vol 457. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4811-9\_27

Download citation

Publish with us